Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses
Research and development expenses, net of government assistance	$ (460)	$ (3,292)	$ (1,555)	$ (5,882)
General and administrative expenses	(1,589)	(1,680)	(3,352)	(3,599)
Sales and marketing	(43)	(136)	(154)	(357)
Restructuring cost	0	0	(1,485)	0
Loss from operating activities	(2,092)	(5,108)	(6,546)	(9,838)
Foreign exchange gain (loss)	(13)	(12)	(5)	(90)
Change in fair value of warrant liabilities	(1,826)	0	(1,826)	10
Interest income and other expense	212	36	346	68
Total other income (loss), net	(1,627)	24	(1,485)	(12)
Loss before income tax recovery	(3,719)	(5,084)	(8,031)	(9,850)
Income tax recovery	446	155	735	397
Net loss and total comprehensive loss	$ (3,273)	$ (4,929)	$ (7,296)	$ (9,453)
Loss per share, Basic	$ (0.43)	$ (0.66)	$ (0.97)	$ (1.28)
Loss per share, Diluted	$ (0.43)	$ (0.66)	$ (0.97)	$ (1.28)
Weighted Average Number of Shares Outstanding, Basic	7,552,677	7,425,166	7,494,425	7,406,689
Weighted Average Number of Shares Outstanding, Diluted	7,552,677	7,425,166	7,494,425	7,406,689